...
首页> 外文期刊>Drug Design, Development and Therapy >Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin
【24h】

Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin

机译:转铁蛋白修饰的肿瘤靶向共聚物纳米载体的合成与表征

获取原文
           

摘要

Abstract: To increase the encapsulation of hydrophilic antitumor agent daunorubicin (DNR) and multidrug resistance reversal agent tetrandrine (Tet) in the drug delivery system of nanoparticles (NPs), a functional copolymer NP composed of poly(lactic-co-glycolic acid) (PLGA), poly-l-lysine (PLL), and polyethylene glycol (PEG) was synthesized and then loaded with DNR and Tet simultaneously to construct DNR/Tet–PLGA–PLL–PEG-NPs using a modified double-emulsion solvent evaporation/diffusion method. And to increase the targeted antitumor effect, DNR/Tet–PLGA–PLL–PEG-NPs were further modified with transferrin (Tf) due to its specific binding to Tf receptors (TfR), which is highly expressed on the surface of tumor cells. In this study, the influence of the diversity of formulation parameters was investigated systematically, such as drug loading, mean particle size, molecular weight, the concentration of PLGA–PLL–PEG–Tf, volume ratio of acetone to dichloromethane, the concentration of polyvinyl alcohol (PVA) in the external aqueous phase, the volume ratio of the internal aqueous phase to the external aqueous phase, and the type of surfactants in the internal aqueous phase. Meanwhile, its possible effect on cell viability was evaluated. Our results showed that the regular spherical DNR/Tet–PLGA–PLL–PEG–Tf-NPs with a smooth surface, a relatively low polydispersity index, and a diameter of 213.0±12.0 nm could be produced. The encapsulation efficiency was 70.23%±1.91% for DNR and 86.5%±0.70% for Tet, the moderate drug loading was 3.63%±0.15% for DNR and 4.27%±0.13% for Tet. Notably, the accumulated release of DNR and Tet could be sustained over 1 week, and the Tf content was 2.18%±0.04%. In cell viability tests, DNR/Tet–PLGA–PLL–PEG–Tf-NPs could inhibit the proliferation of K562/ADR cells in a dose-dependent manner, and the half maximal inhibitory concentration value (total drug) of DNR/Tet–PLGA–PLL–PEG–Tf-NPs was lower than that of DNR, a mixture of DNR and Tet, and DNR/Tet–PLGA–PLL–PEG-NPs. These results clearly indicate that the PLGA–PLL–PEG formulation is a potential drug delivery system for hydrophilic and hydrophobic drugs, and that Tf modification may increase its targeting properties.
机译:摘要:为了增加亲水性抗肿瘤药柔红霉素(DNR)和多药抗性逆转剂粉防己碱(Tet)在纳米颗粒(NPs)的给药系统中的包裹性,该纳米颗粒是由聚乳酸-乙醇酸共聚物组成的功能共聚物NP(合成PLGA),聚l赖氨酸(PLL)和聚乙二醇(PEG),然后同时使用DNR和Tet进行负载,以使用改良的双乳液溶剂蒸发/分离技术构建DNR / Tet-PLGA-PLL-PEG-NPs。扩散法。为了提高靶向抗肿瘤作用,由于DNR / Tet-PLGA-PLL-PEG-NP与Tf受体(TfR)特异结合,并在肿瘤细胞表面高表达,因此用转铁蛋白(Tf)对其进行了进一步修饰。在这项研究中,系统地研究了制剂参数多样性的影响,例如载药量,平均粒径,分子量,PLGA–PLL–PEG–Tf的浓度,丙酮与二氯甲烷的体积比,聚乙烯醇的浓度外水相中的醇(PVA),内水相与外水相的体积比以及内水相中表面活性剂的类型。同时,评估了其对细胞活力的可能影响。我们的结果表明,可以制得规则的球形DNR / Tet-PLGA-PLL-PEG-Tf-NPs,它们具有光滑的表面,较低的多分散指数和213.0±12.0 nm的直径。 DNR的包封率为70.23%±1.91%,Tet的包封率为86.5%±0.70%,DNR的中度载药量为3.63%±0.15%,Tet的为4.27%±0.13%。值得注意的是,DNR和Tet的累积释放可以持续超过1周,并且Tf含量为2.18%±0.04%。在细胞生存力测试中,DNR / Tet–PLGA–PLL–PEG–Tf-NPs可以剂量依赖性的方式抑制K562 / ADR细胞的增殖,而DNR / Tet–200的最大抑制浓度值(总药物)的一半PLGA–PLL–PEG–Tf-NPs低于DNR,DNR和Tet以及DNR / Tet–PLGA–PLL–PEG-NPs的混合物。这些结果清楚地表明,PLGA–PLL–PEG制剂是用于亲水和疏水药物的潜在药物递送系统,并且Tf修饰可能会提高其靶向性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号